Monitoring of noninvasive ventilation: comparative analysis of different strategies.
Aged
Blood Gas Analysis
Blood Gas Monitoring, Transcutaneous
Capnography
Chronic Disease
Female
Humans
Lung
/ physiopathology
Male
Middle Aged
Noninvasive Ventilation
/ instrumentation
Polysomnography
Predictive Value of Tests
Reproducibility of Results
Respiratory Insufficiency
/ diagnosis
Retrospective Studies
Software
Time Factors
Treatment Outcome
Ventilators, Mechanical
Bi-level positive airway pressure
Monitoring
Nocturnal pulse oximetry
Non-invasive ventilation
Respiratory failure
Transcutaneous capnography
Journal
Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633
Informations de publication
Date de publication:
10 Dec 2020
10 Dec 2020
Historique:
received:
27
12
2019
accepted:
24
11
2020
entrez:
11
12
2020
pubmed:
12
12
2020
medline:
8
10
2021
Statut:
epublish
Résumé
Noninvasive ventilation (NIV) represents an effective treatment for chronic respiratory failure. However, empirically determined NIV settings may not achieve optimal ventilatory support. Therefore, the efficacy of NIV should be systematically monitored. The minimal recommended monitoring strategy includes clinical assessment, arterial blood gases (ABG) and nocturnal transcutaneous pulsed oxygen saturation (SpO This retrospective comparative study evaluated the efficacy of NIV in consecutive patients through four strategies (A, B, C and D) using four different tools in various combinations. These tools included morning ABG, nocturnal SpO NIV was appropriate in only 29 of the 100 included patients. Strategy A considered 53 patients as appropriately ventilated. Strategy B considered 48 patients as appropriately ventilated. Strategy C misclassified only 6 patients with daytime hypercapnia. Monitoring ABG and nocturnal SpO
Sections du résumé
BACKGROUND
BACKGROUND
Noninvasive ventilation (NIV) represents an effective treatment for chronic respiratory failure. However, empirically determined NIV settings may not achieve optimal ventilatory support. Therefore, the efficacy of NIV should be systematically monitored. The minimal recommended monitoring strategy includes clinical assessment, arterial blood gases (ABG) and nocturnal transcutaneous pulsed oxygen saturation (SpO
METHODS
METHODS
This retrospective comparative study evaluated the efficacy of NIV in consecutive patients through four strategies (A, B, C and D) using four different tools in various combinations. These tools included morning ABG, nocturnal SpO
RESULTS
RESULTS
NIV was appropriate in only 29 of the 100 included patients. Strategy A considered 53 patients as appropriately ventilated. Strategy B considered 48 patients as appropriately ventilated. Strategy C misclassified only 6 patients with daytime hypercapnia.
CONCLUSION
CONCLUSIONS
Monitoring ABG and nocturnal SpO
Identifiants
pubmed: 33302961
doi: 10.1186/s12931-020-01586-8
pii: 10.1186/s12931-020-01586-8
pmc: PMC7725884
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
324Références
J Thorac Dis. 2018 Jan;10(Suppl 1):S80-S85
pubmed: 29445531
Respir Med. 2018 Nov;144:30-35
pubmed: 30366581
Respir Med. 2016 Mar;112:112-8
pubmed: 26874895
Chest. 2020 Jul;158(1):279-291
pubmed: 32243941
Thorax. 2012 Jun;67(6):546-52
pubmed: 20971982
Sleep. 1981;4(1):93-7
pubmed: 7232974
J Clin Sleep Med. 2010 Oct 15;6(5):491-509
pubmed: 20957853
Respir Med. 2009 Feb;103(2):165-72
pubmed: 18579368
Thorax. 2005 Dec;60(12):1019-24
pubmed: 16299118
Rev Mal Respir. 2018 Jan;35(1):88-93
pubmed: 29395564
Chest. 2008 Jun;133(6):1421-1425
pubmed: 18339783
Thorax. 2011 Jan;66(1):82-4
pubmed: 20729234
Arch Phys Med Rehabil. 2013 Jan;94(1):46-52
pubmed: 22964272
Lung. 1990;168 Suppl:770-5
pubmed: 2117190
Sleep. 1997 Jul;20(7):561-9
pubmed: 9322272
Respir Care. 2010 Oct;55(10):1347-62; discussion 1363-5
pubmed: 20875161
Chest. 1992 Mar;101(3):649-55
pubmed: 1541127
Respirology. 2014 Aug;19(6):857-65
pubmed: 24912564
Chest. 2007 Apr;131(4):1090-9
pubmed: 17426214
Chest. 2012 Aug;142(2):367-376
pubmed: 22406958
Front Med (Lausanne). 2016 Sep 13;3:40
pubmed: 27679799
Thorax. 2000 May;55(5):417-23
pubmed: 10770824
Eur Respir J. 2009 Oct;34(4):902-13
pubmed: 19324951
Intensive Care Med. 2008 Jul;34(7):1340-4
pubmed: 18365170
Eur Respir J. 1992 Mar;5(3):301-7
pubmed: 1572442
Respiration. 2019;97(2):93-104
pubmed: 30423557
Eur Respir J. 2019 May 23;53(5):
pubmed: 30880286
Chest. 2012 Feb;141(2):469-476
pubmed: 21778253
Eur Respir J. 2005 Jun;25(6):1025-31
pubmed: 15929957
Sleep Med Rev. 2002 Feb;6(1):29-44
pubmed: 12531140
Intensive Care Med. 2009 Jun;35(6):1068-74
pubmed: 19172246
Lancet Neurol. 2006 Feb;5(2):140-7
pubmed: 16426990
J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1045-50
pubmed: 27090433
Eur Respir Rev. 2013 Sep 1;22(129):325-32
pubmed: 23997060
Thorax. 2011 Feb;66(2):170-8
pubmed: 20947891
Eur Respir J Suppl. 2003 Nov;47:38s-46s
pubmed: 14621116
Pediatr Pulmonol. 2011 Aug;46(8):802-8
pubmed: 21337731
Thorax. 2011 May;66(5):438-45
pubmed: 20971980
Respir Care. 2012 Sep;57(9):1425-30
pubmed: 22348449
Respirology. 2016 Oct;21(7):1300-6
pubmed: 27185178
Intensive Care Med. 2013 Apr;39(4):739-46
pubmed: 23344829
Eur Respir J. 1999 Dec;14(6):1251-7
pubmed: 10624751
Thorax. 2015 Oct;70(10):946-52
pubmed: 26197816
Respir Care. 2006 Oct;51(10):1162-6
pubmed: 17005062
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep;14(5-6):373-9
pubmed: 23527531
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Respir Med. 2017 Nov;132:210-216
pubmed: 29229100
JAMA. 2017 Jun 6;317(21):2177-2186
pubmed: 28528348